THERAPEUTIC AGENT FOR CORNEAL SENSORY NERVE DAMAGE CONTAINING SEMAPHORIN INHIBITOR AS ACTIVE INGREDIENT
A compound represented by formula (1), or a pharmaceutically acceptable salt thereof is effective as a therapeutic agent or a prophylactic agent for a corneal disease or sensory nerve damage due to corneal surgery, and as a regeneration accelerator for corneal sensory nerves: wherein R 1 represents a hydrogen atom or a carboxyl group, R 2 represents a hydrogen atom or a hydroxy group, R 3 represents a hydrogen atom or a carboxyl group, and R 4 represents a hydrogen atom or a hydroxy group.
1 . A method for treating or preventing sensory neuropathy caused by corneal disease or corneal surgery, comprising administering a compound represented by the following formula (1) or a pharmaceutically acceptable salt thereof:
wherein R 1 represents a hydrogen atom, a carboxyl group, or an alkoxycarbonyl group; R 2 represents a hydrogen atom, a hydroxyl group, or an acyloxy group; R 3 represents a hydrogen atom, a carboxyl group, or an alkoxycarbonyl group; and R 4 represents a hydrogen atom, a hydroxyl group, or an acyloxy group.
2 . The therapeutic or preventive method according to claim 1 , wherein, in the formula (1), at least one of R 2 and R 4 represents a hydroxyl group.
3 . The therapeutic or preventive method according to claim 2 , wherein, in the formula (1), R 2 represents a hydroxyl group.
4 . The therapeutic or preventive method according to claim 2 , wherein, in the formula (1), R 2 and R 4 each represent a hydroxyl group.
5 . The therapeutic or preventive method according to claim 1 , wherein, in the formula (1), at least one of R 1 and R 3 represents a carboxyl group.
6 . The therapeutic or preventive method according to claim 5 , wherein, in the formula (1), R 3 represents a carboxyl group.
7 . The therapeutic or preventive method according to claim 1 , wherein, in the formula (1), R 1 and R 3 each represent a carboxyl group, and R 2 and R 4 each represent a hydroxyl group.
8 . The therapeutic or preventive method according to claim 1 , wherein the corneal disease is keratitis, leukoma, corneal infection, corneal degeneration, corneal dystrophy, corneal stromal dystrophy, bullous keratopathy, keratoconus, corneal decompensation, corneal ulcer, neuroparalytic keratopathy, diabetic keratopathy, chemical burns of the cornea, or thermal burns of the cornea.
9 . The therapeutic or preventive method according to claim 1 , wherein the corneal surgery is keratoplasty.
10 . The therapeutic or preventive method according to claim 1 , wherein the corneal surgery is myopia correction surgery.
11 . The therapeutic or preventive method according to claim 1 , wherein the corneal surgery targets the cornea required for the treatment of eye disease or corneal injury.
12 . The therapeutic or preventive method according to claim 1 , wherein the sensory neuropathy caused by the corneal sensory nerve damaged due to corneal disease or corneal surgery is imperception.
13 . The therapeutic or preventive method according to claim 1 , wherein the sensory neuropathy caused by the corneal sensory nerve damaged due to corneal disease or corneal surgery is dry eyes.
14 . The therapeutic or preventive method according to claim 1 wherein the compound represented by the formula (1) or a pharmaceutically acceptable salt thereof is administered in the form of ophthalmic preparations.
15 . A method for promoting the regeneration of corneal sensory nerve, comprising, administering the compound represented by the formula (1) or a pharmaceutically acceptable salt thereof to a subject in need thereof.
16 . The regeneration promotion method according to claim 15 , wherein the method is used for treatment or prevention of sensory neuropathy caused by corneal disease or corneal surgery.
17 . The regeneration promotion method according to claim 16 , wherein the sensory neuropathy caused by corneal disease or corneal surgery is imperceptions.
18 . The regeneration promotion method according to claim 16 , wherein the sensory neuropathy caused by corneal disease or corneal surgery is dry eyes.
19 . The regeneration promotion method according to claim 15 , wherein the promoter is in the form of ophthalmic preparations.
20 . The therapeutic or preventive method according claim 1 , wherein, in the formula (1), R 1 represents a hydrogen atom or a carboxyl group, R 2 represents a hydrogen atom or a hydroxyl group, R 3 represents a hydrogen atom or a carboxyl group, and R 4 represents a hydrogen atom or a hydroxyl group.